BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding 'Balaxi Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of Key Managerial Personnel authorized to determine materiality of event for making disclosure to the Stock Exchanges'.'.
BALAXI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Balaxi Pharmaceuticals Limited has informed the stock exchange that the Board of Directors has authorized two Key Managerial Personnel to determine the materiality of events and make disclosures to stock exchanges under Regulation 30(5) of SEBI Listing Regulations. The authorized KMPs are Mr. Ashish Maheshwari (Chairman and Managing Director) and Mr. Aman Purohit (Company Secretary and Compliance Officer). Both are authorized severally, meaning either one can act independently. The contact details for both officials based in Hyderabad have been disclosed. This is a routine compliance filing required under SEBI regulations and does not involve any business or financial event.
This is a procedural regulatory disclosure with no impact on the company's financials or operations. It simply identifies which executives are responsible for assessing and reporting material events to the stock exchanges going forward.